Global Law Firm Hogan Lovells Cadwalader Advises Jazz Pharmaceuticals on Acquisition of Actio Biosciences
August 12, 2026
August 12, 2026
LONDON, England, Aug. 12 -- Hogan Lovells Cadwalader, a law firm, issued the following news release:
* * *
Global law firm Hogan Lovells Cadwalader advises Jazz Pharmaceuticals on acquisition of Actio Biosciences
Silicon Valley - Global law firm Hogan Lovells Cadwalader has advised Jazz Pharmaceuticals plc (Nasdaq: JAZZ) on its definitive agreement to acquire privately-held Actio Biosciences, Inc. for US$820 million upfront and up to US$500 million in conti . . .
* * *
Global law firm Hogan Lovells Cadwalader advises Jazz Pharmaceuticals on acquisition of Actio Biosciences
Silicon Valley - Global law firm Hogan Lovells Cadwalader has advised Jazz Pharmaceuticals plc (Nasdaq: JAZZ) on its definitive agreement to acquire privately-held Actio Biosciences, Inc. for US$820 million upfront and up to US$500 million in conti . . .